184 related articles for article (PubMed ID: 8454032)
1. Glycosyl phosphatidylinositols in Trypanosoma brucei.
Raper J; Doering TL; Buxbaum LU; Englund PT
Exp Parasitol; 1993 Mar; 76(2):216-20. PubMed ID: 8454032
[No Abstract] [Full Text] [Related]
2. Designing sleeping sickness control.
Kinoshita T
ACS Chem Biol; 2008 Oct; 3(10):601-3. PubMed ID: 18928247
[TBL] [Abstract][Full Text] [Related]
3. Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness.
Smith TK; Crossman A; Brimacombe JS; Ferguson MA
EMBO J; 2004 Nov; 23(23):4701-8. PubMed ID: 15526036
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrate-binding agents act as potent trypanocidals that elicit modifications in VSG glycosylation and reduced virulence in Trypanosoma brucei.
Castillo-Acosta VM; Vidal AE; Ruiz-Pérez LM; Van Damme EJ; Igarashi Y; Balzarini J; González-Pacanowska D
Mol Microbiol; 2013 Nov; 90(4):665-79. PubMed ID: 23926900
[TBL] [Abstract][Full Text] [Related]
5. Specialized fatty acid synthesis in African trypanosomes: myristate for GPI anchors.
Morita YS; Paul KS; Englund PT
Science; 2000 Apr; 288(5463):140-3. PubMed ID: 10753118
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis of the glycosyl phosphatidylinositol anchor of Trypanosoma brucei variant surface glycoprotein.
Masterson WJ
Biochem Soc Trans; 1990 Oct; 18(5):722-4. PubMed ID: 2150651
[No Abstract] [Full Text] [Related]
7. Glycosyl-phosphatidylinositols of Trypanosoma congolense: two common precursors but a new protein-anchor.
Gerold P; Striepen B; Reitter B; Geyer H; Geyer R; Reinwald E; Risse HJ; Schwarz RT
J Mol Biol; 1996 Aug; 261(2):181-94. PubMed ID: 8757286
[TBL] [Abstract][Full Text] [Related]
8. The glycosylation of the variant surface glycoproteins and procyclic acidic repetitive proteins of Trypanosoma brucei.
Mehlert A; Zitzmann N; Richardson JM; Treumann A; Ferguson MA
Mol Biochem Parasitol; 1998 Mar; 91(1):145-52. PubMed ID: 9574932
[TBL] [Abstract][Full Text] [Related]
9. Myristate exchange in glycolipid A and VSG of African trypanosomes.
Buxbaum LU
Braz J Med Biol Res; 1994 Feb; 27(2):115-9. PubMed ID: 8081218
[TBL] [Abstract][Full Text] [Related]
10. Trypanasome coat provides potential for new drugs.
Sansum C
Lancet Infect Dis; 2001 Sep; 1(2):70. PubMed ID: 11871470
[No Abstract] [Full Text] [Related]
11. Structure of the glycosylphosphatidylinositol membrane anchor glycan of a class-2 variant surface glycoprotein from Trypanosoma brucei.
Mehlert A; Richardson JM; Ferguson MA
J Mol Biol; 1998 Mar; 277(2):379-92. PubMed ID: 9514751
[TBL] [Abstract][Full Text] [Related]
12. Glycosyl phosphatidylinositol myristoylation in African trypanosomes.
Werbovetz KA; Englund PT
Mol Biochem Parasitol; 1997 Mar; 85(1):1-7. PubMed ID: 9108544
[No Abstract] [Full Text] [Related]
13. In vitro trypanocidal activity of the anti-helminthic drug niclosamide.
Merschjohann K; Steverding D
Exp Parasitol; 2008 Apr; 118(4):637-40. PubMed ID: 18226810
[TBL] [Abstract][Full Text] [Related]
14. [Rational concepts and the study of active molecules against various trypanosomiases].
Périé J; de Albuquerque C; Blonski C; Chauvière G; Gefflaut T; Page P; Trinquier M; Willson M
Bull Soc Pathol Exot; 1994; 87(5):353-61. PubMed ID: 7496200
[TBL] [Abstract][Full Text] [Related]
15. The core glycosylphosphatidylinositol anchor structures of Trypanosoma brucei variant surface glycoprotein 221.
Mehlert A; Richardson JM; Ferguson MA
Biochem Soc Trans; 1997 Feb; 25(1):13S. PubMed ID: 9056911
[No Abstract] [Full Text] [Related]
16. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluation of the antitrypanosomal activity of fractions of Holarrhena africana.
Nwodo NJ; Brun R; Osadebe PO
J Ethnopharmacol; 2007 Sep; 113(3):556-9. PubMed ID: 17728085
[TBL] [Abstract][Full Text] [Related]
18. The GPI biosynthetic pathway as a therapeutic target for African sleeping sickness.
Ferguson MA; Brimacombe JS; Brown JR; Crossman A; Dix A; Field RA; Güther ML; Milne KG; Sharma DK; Smith TK
Biochim Biophys Acta; 1999 Oct; 1455(2-3):327-40. PubMed ID: 10571022
[TBL] [Abstract][Full Text] [Related]
19. The biochemistry of African trypanosomes and its significance for chemotherapy.
Braide VB
J Vet Pharmacol Ther; 1987 Sep; 10(3):191-201. PubMed ID: 3309362
[No Abstract] [Full Text] [Related]
20. Trypanosome glucose transporters.
Barrett MP; Tetaud E; Seyfang A; Bringaud F; Baltz T
Mol Biochem Parasitol; 1998 Mar; 91(1):195-205. PubMed ID: 9574935
[No Abstract] [Full Text] [Related]
[Next] [New Search]
